Oxygenta Pharmaceutical Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

In compliance with provisions of Regulation 39(3)of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD RTAMB/P/CIR/2022/8 dated 25 January 2022, the Company hereby inform that Letter of Confirmation has been issued to the below mentioned shareholder for effecting issuance of Duplicate Share Certificate in dematerialized mode We request you to kindly take the same on record. Thanking you